Subscribe to RSS
DOI: 10.1055/s-0029-1217515
One-Pot Synthesis of Functionalized Benzimidazoles and 1H-Pyrimidines via Cascade Reactions of o-Aminoanilines or Naphthalene-1,8-diamine with Alkynes and p-Tolylsulfonyl Azide
Publication History
Publication Date:
25 June 2009 (online)

Abstract
A one-pot synthesis of functionalized benzimidazoles and 1H-pyrimidines via the cascade reactions of o-aminoanilines or naphthalene-1,8-diamine with terminal alkynes and p-tolylsulfonyl azide is reported. The protocol is efficient and general.
Key words
benzimidazole - 1H-pyrimidine - o-aminoanilines - naphthalene-1,8-diamine - alkynes
- Supporting Information for this article is available online:
- Supporting Information
- For selected examples, see:
- 1a
Hauel NH.Nar H.Priepke H.Ries U.Stassen J.Wienen W. J. Med. Chem. 2002, 45: 1757 - 1b
Morphy R.Rankovic Z. J. Med. Chem. 2005, 48: 6523 - 1c
Mann J.Baron A.Opoku-Boahen Y.Hohansson E.Parkinson G.Kelland LR.Neidle S. J. Med. Chem. 2001, 41: 138 - 1d
Ishida T.Suzuki T.Hirashima S.Mizutani K.Yoshida A.Ando I.Ikeda S.Adachi T.Hashimoto H. Bioorg. Med. Chem. Lett. 2006, 41: 985 - 1e
Roth T.Morningstar ML.Boyer PL.Hughes SH.Buckheit RW.Michejda CJ.
J. Med. Chem. 1997, 40: 4199 - 1f
Chen AY.Yu C.Gatto B.Liu LF. Proc. Natl. Acad. Sci. U.S.A. 1993, 90: 8131 - 1g
Soderlind K.-J.Gorodetsky B.Singh AK.Bachur N.Miller GG.Lown JW. Anti-cancer Drug Design 1999, 14: 19 - For selected examples, see:
- 2a
Xu H.Xu Z.-F.Yue Z.-Y.Yan P.-F.Wang B.Jia L.-W.Li G.-M.Sun W.-B.Zhang J.-W. J. Phys. Chem. C 2008, 112: 15517 - 2b
Muller G.Bnzli J.-CG.Schenk KJ.Piguet C.Hopfgartner G. Inorg. Chem. 2001, 40: 2642 - 2c
Xia C.-K.Lu C.-Z.Zhang Q.-Z.He X.Zhang J.-J.Wu D.-M. Cryst. Growth Des. 2005, 5: 1569 - 2d
Fekner T.Gallucci Chan MK. J. Am. Chem. Soc. 2004, 126: 223 - For selected examples, see:
- 3a
Schwartz G.Fehse K.Pfeiffer M.Walzer K.Leo K. Appl. Phys. Lett. 2006, 89: 83509 - 3b
Erten S.Eren T.Icli S. Eur. Phys. J. Appl. Phys. 2007, 38: 227 - For selected examples, see:
- 4a
Weber J.Antonietti M.Thomas A. Macromolecules 2007, 40: 1299 - 4b
Qing S.Huang W.Yan D. Eur. Polym. J. 2005, 41: 1589 - 4c
Asensio JA.Gomez-Romero P. Fuel Cells 2005, 5: 336 - 5a
Meng L.Fettinger JC.Kurth MJ. Org. Lett. 2007, 9: 5055 - 5b
Katritzky AR.Lan XF.Yang JZ.Denisko OV. Chem. Rev. 1998, 98: 409 - 5c
Dudd LM.Venardou E.Garcia-Verdugo E.Licence P.Blake AJ.Wilson C.Poliakoff M. Green Chem. 2003, 5: 187 - 5d
Carpenter RD.DeBerdt PB.Lam KS.Kurth MJ. J. Comb. Chem. 2006, 8: 909 - 5e
Zhang Z.-H.Yin L.Wang Y.-M. Catal. Commun. 2007, 8: 1126 - 6a
VanVlier DS.Gillespiean P.Scicinski J. Tetrahedron Lett. 2005, 46: 6741 - 6b
Hornberger KR.Adjabeng GM.Dickson HD.Davis-Ward RG. Tetrahedron Lett. 2006, 47: 5359 - 6c
Wu Z.Rea P.Wickham G. Tetrahedron Lett. 2000, 41: 9871 - 6d
Yang D.Fokas D.Li J.Yu L.Baldino CM. Synthesis 2005, 47 - 7a
Du LH.Wang YG. Synthesis 2007, 675 - 7b
Lin S.Yang L. Tetrahedron Lett. 2005, 46: 4315 - 7c
Gogoi P.Konwar D. Tetrahedron Lett. 2006, 47: 79 - 7d
Harapanhalli RS.McLaughlin LW.Howell RW.Rao DV.Adelstein SJ.Kassis AI. J. Med. Chem. 1996, 39: 4804 - 8a
Evindar G.Batey RA. Org. Lett. 2003, 5: 133 - 8b
Yang D.Fu H.Hu L.Jiang Y.Zhao Y. J. Org. Chem. 2008, 73: 7841 - 8c
Zou B.Yuan Q.Ma D. Angew. Chem. Int. Ed. 2007, 46: 2598 - 8d
Brasche G.Buchwald SL. Angew. Chem. Int. Ed. 2008, 47: 1932 - 8e
Murru S.Patel BK.Le Bras J.Muzart J. J. Org. Chem. 2009, 74: 2217 - 9a
Brain CT.Brunton SA. Tetrahedron Lett. 2002, 43: 1893 - 9b
Brain CT.Steer JT. J. Org. Chem. 2003, 68: 6814 - 9c
Zheng N.Anderson KW.Huang X.Nguyen HN.Buchwald SL. Angew. Chem. Int. Ed. 2007, 46: 7509 - 10
Yamamoto Y.Mizuno H.Tsuritani T.Mase T. J. Org. Chem. 2009, 74: 1394 - 11a
Cui SL.Lin XF.Wang YG. Org. Lett. 2006, 8: 4517 - 11b
Cui SL.Wang J.Wang YG. Tetrahedron 2008, 64: 487 - 11c
Cui SL.Wang J.Wang YG. Org. Lett. 2007, 9: 5023 - 11d
Cui SL.Wang J.Wang YG. Org. Lett. 2008, 6: 1267 - 12a
Bae I.Han H.Chang S. J. Am. Chem. Soc. 2005, 127: 2038 - 12b
Cho SH.Yoo EJ.Bae I.Chang S. J. Am. Chem. Soc. 2005, 127: 16046 - 12c
Yoo EJ.Bae I.Cho SH.Han H.Chang S. Org. Lett. 2006, 8: 13470 - 12d
Cassidy MP.Raushel J.Fokin VV. Angew. Chem. Int. Ed. 2006, 45: 3154 - 12e
Whiting M.Fokin VV. Angew. Chem. Int. Ed. 2006, 45: 3157 - 12f
Yoo EJ.Chang S. Org. Lett. 2008, 10: 1163 - 12g
Yoo EJ.Ahlquist M.Bae I.Fokin VV.Chang S.Sharpless KB. J. Org. Chem. 2008, 73: 5520 - 12h
Cho SH.Chang S. Angew. Chem. Int. Ed. 2008, 47: 2836 - 12i
Cho SH.Chang S. Angew. Chem. Int. Ed. 2007, 46: 1897
References and Notes
General Procedure
for the Synthesis of Benzimidazoles and Pyrimidines
To
a solution of p-tolylsulfonyl azide (2.2
mmol), terminal alkyne (2.1 mmol), diamine (o-aminoaniline
or naphthalene-1,8-diamine; 2 mmol), and CuI (0.2 mmol) in MeCN
(10 mL), was added dropwise Et3N (2 mmol). The reaction
was stirred at r.t. under N2 for 6 h, then concd. H2SO4 (98%,
0.4
mL) was added to the reaction mixture. The resulting solution was
heated under reflux for 4 h. After cooling to r.t., the solution
was poured into H2O (20 mL), and neutralized with K2CO3.
MeCN was removed in vacuum, and the resulting solution was extracted
with EtOAc (3 × 5 mL). The organic layer was combined,
dried over anhydrous sodium sulfate, and the solvent was removed
under vacuum. The residue was purified by column chromatography
on silica gel (petroleum ether-EtOAc, 2:1→1:2).
2-Benzyl-1H-benzo[d]imidazole
(5a): White solid; mp 187-188 ˚C; ¹H
NMR (400 MHz, DMSO-d
6): δ = 4.18
(2 H, s), 7.11-7.13 (2 H, m), 7.20-7.24
(1 H, m), 7.29-7.35 (4 H, m), 7.48 (2 H,
br s), 12.32 (1 H, br s); ¹³C
NMR (100 MHz, DMSO-d
6): δ = 35.4,
121.7, 126.9, 128.9, 129.1, 138.1, 153.9; IR (KBr): 3432, 3083,
3050, 3025, 2837, 2738, 2687, 2637, 1624, 1588, 1536, 1493, 1457,
1447, 1427, 1323, 1271, 1224, 1196, 1148, 1024, 1013, 1001, 926,
890, 848, 768, 749, 723, 695, 670, 619, 565 cm-¹;
MS (ESI): m/z = 209 [M + H]+;
HRMS (ESI): m/z [M + H]+ calcd
for C14H13N2: 209.1073; found:
209.1073.
2-(4-Methoxybenzyl)-1H-benzo[d]imidazole (5b):
Slightly yellow solid; mp 165-166 ˚C; ¹H
NMR (400 MHz, DMSO-d
6): δ = 3.71
(3 H, s), 4.10 (2 H, s), 6.88 (2 H, d, J = 8.8 Hz), 7.10-7.13
(2 H, m), 7.25 (2 H, d, J = 8.4
Hz), 7.47 (2 H, br s), 12.24 (1 H, br s); ¹³C
NMR (125 MHz, DMSO-d
6): δ = 34.5,
55.4, 114.3, 114.8, 121.5, 129.9, 130.1, 139.2, 154.3, 158.4; IR
(KBr): 3436, 2999, 2937, 2901, 2841, 2759, 1611, 1584, 1537, 1512,
1456, 1442, 1412, 1326, 1305, 1271, 1244, 1184, 1105, 1029, 1000,
922, 838, 814, 769, 752, 729, 715, 573, 511 cm-¹;
MS (ESI): m/z = 239.0 [M + H]+;
HRMS (ESI): m/z [M + H]+ calcd
for C15H15N2O: 239.1179; found: 239.1179.
2-(3-Chlorobenzyl)-1H-Pyrimidine (7a):
Yellow solid; mp 171-173 ˚C; ¹H
NMR (400 MHz, DMSO-d
6): δ = 3.59
(2 H, s), 6.34-6.50 (2 H, br), 6.97-7.09
(4 H, m), 7.32-7.39 (3 H, m), 7.46 (1 H,
s), 10.64 (1 H, br s); ¹³C
NMR (125 MHz, DMSO-d
6): δ = 40.9,
118.8, 121.8, 127.2, 128.0, 128.8, 129.1, 130.8, 133.5, 135.6, 139.7,
156.0; IR (KBr): 3404, 3047, 2813, 1639, 1609, 1597, 1542, 1479,
1445, 1433, 1416, 1369, 1341, 1300, 1241, 1174, 1094, 1078, 1052, 1032,
991, 866, 824, 786, 770, 759, 709, 682, 632 cm-¹;
MS (ESI): m/z = 291.1 [M - H]-;
HRMS (ESI): m/z [M + H]+ calcd
for C18H14ClN2: 293.0840; found:
293.0842.
2-(4-Chlorobenzyl)-1H-Pyrimidine
(7b): Yellow solid; mp 183-185 ˚C; ¹H
NMR (400 MHz, DMSO-d
6): δ = 3.57
(2 H, s), 6.30-6.53 (2 H, br), 6.98 (2
H, d, J = 8.0
Hz), 7.09 (2 H, br), 7.38-7.43 (4 H,
m), 10.64 (1 H, br s); ¹³C
NMR (125 MHz, DMSO-d
6): δ = 40.8,
108.4, 119.1, 121.9, 128.7, 129.0, 131.2, 132.2, 135.7, 136.3, 156.6;
IR (KBr): 3398, 3047, 2927, 2823, 1918, 1635, 1594, 1535, 1491,
1476, 1442, 1425, 1413, 1373, 1342, 1309, 1291, 1238, 1182, 1165,
1092, 1051, 1030, 1017, 988, 825, 805, 793, 765, 713, 692, 616,
512 cm-¹; MS (ESI): m/z = 291 [M - H]-;
HRMS (ESI): m/z [M + H]+ calcd
for C18H14ClN2: 293.0840; found: 293.0829.